These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 150989)

  • 1. The diabetogenic activity of fragments of human growth hormone in obese (ob/ob) mice.
    Reagan CR
    Diabetes; 1978 Sep; 27(9):883-8. PubMed ID: 150989
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetogenic activity of native and biosynthetic human growth hormone in obese (ob/ob) mouse.
    Kostyo JL; Gennick SE; Sauder SE
    Am J Physiol; 1984 Apr; 246(4 Pt 1):E356-60. PubMed ID: 6720889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cycloheximide on acute diabetogenic effects of S-carboxymethylated human growth hormone in obese (ob/ob) mice.
    Adamafio NA; Cameron CM; Kostyo JL
    Horm Metab Res; 1988 Jul; 20(7):391-4. PubMed ID: 3049288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant-DNA-derived modification of human growth hormone (hGH44-191) with enhanced diabetogenic activity.
    Lewis UJ; Lewis LJ; Salem MA; Staten NR; Galosy SS; Krivi GG
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):45-54. PubMed ID: 1936524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthetic 20-kilodalton methionyl-human growth hormone has diabetogenic and insulin-like activities.
    Kostyo JL; Cameron CM; Olson KC; Jones AJ; Pai RC
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4250-3. PubMed ID: 3889926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced and S-carboxymethylated human growth hormone: a probe for diabetogenic action.
    Cameron CM; Kostyo JL; Rillema JA; Gennick SE
    Am J Physiol; 1984 Nov; 247(5 Pt 1):E639-44. PubMed ID: 6496734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
    Towns R; Kostyo JL; Colca JR
    Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth factor from plerocercoid larvae of the tapeworm, Spirometra mansonoides, stimulates growth but is not diabetogenic.
    Salem MA; Phares CK
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):187-92. PubMed ID: 2726784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hyperglycemic peptide from pituitary growth hormone: preparation with pepsin and assay in ob-ob mice.
    Lostroh AJ; Krahl ME
    Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1244-6. PubMed ID: 4598296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetogenic peptide from human growth hormone: partial purification from peptic digest and long-term action in ob/ob mice.
    Lostroh AJ; Krahl ME
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4706-10. PubMed ID: 1070022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hybrid noncovalent complex of fragments of porcine and human growth hormones with diabetogenic activity.
    Gennick SE; Kostyo JL; Mills JB; Eden S
    Endocrinology; 1983 Jun; 112(6):2069-75. PubMed ID: 6303758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic fragment of human growth hormone with hyperglycemic properties: residues 44-77.
    Lostroh AJ; Krahl ME
    Diabetes; 1978 May; 27(5):597-8. PubMed ID: 648751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypsin-resistant forms of human growth hormone have diabetogenic and insulin-like activities.
    Cameron CM; Kostyo JL; Kumar V; Gennick SE
    Biochim Biophys Acta; 1985 Sep; 841(3):254-60. PubMed ID: 3896320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice.
    Green BD; Irwin N; Gault VA; Bailey CJ; O'Harte FP; Flatt PR
    J Endocrinol; 2005 May; 185(2):307-17. PubMed ID: 15845923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of age on responsiveness to diabetogenic action of growth hormone.
    Cameron CM; Kostyo JL
    Diabetes; 1987 Jan; 36(1):88-92. PubMed ID: 3539676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolism.
    Heffernan MA; Jiang WJ; Thorburn AW; Ng FM
    Am J Physiol Endocrinol Metab; 2000 Sep; 279(3):E501-7. PubMed ID: 10950816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20-kDa placental hGH-V has diminished diabetogenic and lactogenic activities compared with 22-kDa hGH-N while retaining antilipogenic activity.
    Vickers MH; Gilmour S; Gertler A; Breier BH; Tunny K; Waters MJ; Gluckman PD
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E629-37. PubMed ID: 19509186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice.
    Parker JC; Lavery KS; Irwin N; Green BD; Greer B; Harriott P; O'Harte FP; Gault VA; Flatt PR
    J Endocrinol; 2006 Oct; 191(1):93-100. PubMed ID: 17065392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of cumulative body weight gain and adipose tissue mass in obese mice: response to chronic treatment with synthetic hGH 177-191 peptide.
    Natera SH; Jiang WJ; Ng FM
    Biochem Mol Biol Int; 1994 Aug; 33(5):1011-21. PubMed ID: 7987248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.